Back
MiNK Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
32
INKT
MiNK Therapeutics, Inc.
Last Price:
$11.68
Seasonality Move:
-18.07%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INKT is experiencing slight buying pressure.
MiNK Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.09 | Sell |
| 20-day SMA: | 11.62 | Sell |
| 50-day SMA: | 12.8 | Sell |
| 200-day SMA: | 11.89 | Sell |
| 8-day EMA: | 11.86 | Sell |
| 20-day EMA: | 11.96 | Sell |
| 50-day EMA: | 12.6 | Sell |
| 200-day EMA: | 12.22 | Sell |
MiNK Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.19 | Sell |
| Relative Strength Index (14 RSI): | 44.79 | Sell |
| Chaikin Money Flow: | 9780 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.89 - 12.35) | Sell |
| Bollinger Bands (100): | (12.23 - 15.15) | Sell |
MiNK Therapeutics, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for MiNK Therapeutics, Inc. Stock
Is MiNK Therapeutics, Inc. Stock a Buy?
-
MiNK Therapeutics, Inc. share price is 11.59 while INKT 8-day simple moving average is 12.09, which is a Sell signal.
-
The stock price of INKT is 11.59 while MiNK Therapeutics, Inc. 20-day SMA is 11.62, which makes it a Sell.
-
MiNK Therapeutics, Inc. 50-day simple moving average is 12.80 while INKT share price is 11.59, making it a Sell technically.
-
INKT stock price is 11.59 and MiNK Therapeutics, Inc. 200-day simple moving average is 11.89, creating a Sell signal.
INKT Technical Analysis vs Fundamental Analysis
Sell
32
MiNK Therapeutics, Inc. (INKT)
is a Sell
Is MiNK Therapeutics, Inc. a Buy or a Sell?
-
MiNK Therapeutics, Inc. stock is rated a SellThe current MiNK Therapeutics, Inc. [INKT] share price is $11.59. The Score for INKT is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
MiNK Therapeutics, Inc. Stock Info
Market Cap:
54.4M
Price in USD:
11.59
Share Volume:
32.1K
MiNK Therapeutics, Inc. 52-Week Range
52-Week High:
76.00
52-Week Low:
4.56
Sell
32
MiNK Therapeutics, Inc. (INKT)
is a Sell
MiNK Therapeutics, Inc. Share Price Forecast
-
What is the MiNK Therapeutics, Inc. stock price today?The MiNK Therapeutics, Inc. stock price is 11.59 USD today.
-
Will INKT stock go up or go down?MiNK Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is MiNK Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, MiNK Therapeutics, Inc. is overvalued.
Is MiNK Therapeutics, Inc. Stock a Buy?
-
MiNK Therapeutics, Inc. share price is 11.59 while INKT 8-day exponential moving average is 11.86, which is a Sell signal.
-
The stock price of INKT is 11.59 while MiNK Therapeutics, Inc. 20-day EMA is 11.96, which makes it a Sell.
-
MiNK Therapeutics, Inc. 50-day exponential moving average is 12.60 while INKT share price is 11.59, making it a Sell technically.
-
INKT stock price is 11.59 and MiNK Therapeutics, Inc. 200-day simple moving average is 12.22, creating a Sell signal.
Fundamental Analysis of MiNK Therapeutics, Inc.
Is MiNK Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and a decrease next year of $0.82 per share.
Technical Analysis of MiNK Therapeutics, Inc.
Should I short MiNK Therapeutics, Inc. stock?
-
INKT Moving Average Covergence Divergence (MACD) indicator is -0.19, suggesting MiNK Therapeutics, Inc. is a Sell
-
MiNK Therapeutics, Inc. Relative Strength Index (RSI) is 44.79, which suggest MiNK Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for MiNK Therapeutics, Inc. is (10.89 - 12.35), which suggest MiNK Therapeutics, Inc. is a Sell
-
The Bollinger Bands (100) for MiNK Therapeutics, Inc. is (12.23 - 15.15), which suggest MiNK Therapeutics, Inc. is a Sell
* MiNK Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.